CryoCath Provides Update on Patent Infringeme...( http://www MONTREAL Fe...),Health

http://www.cryocath.com Toronto Stock Exchange Symbol: CYT

MONTREAL, Feb. 14 /PRNewswire-FirstCall/ - CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today provided an update on the enforcement of its patent portfolio.

Since its inception 13 years ago CryoCath has been, and continues to be the clear leader in innovation in the field of cryotherapy devices with cardiac applications and will continue to vigorously enforce its patent rights. CryoCath owns over 100 issued patents world-wide and has more than 100 patent applications pending. In the last five years, CryoCath has filed over 140 patent applications. Many of CryoCath's pending applications are expected to issue between 2008 and 2010, continuing to strengthen CryoCath's intellectual property position.

In October 2007, CryoCath filed a U.S. patent infringement suit against CryoCor, Inc. alleging infringement of six patents. Since that time, the United States Patent and Trademark Office (USPTO) has issued CryoCath two additional patents, U.S. Patent Nos. 7,303,554 and 7,318,821. CryoCath will amend its complaint to assert these patents in this patent infringement suit.

In early February 2008, CryoCath also filed a claim against CryoCor, alleging infringement of a ninth CryoCath patent, U.S. Patent # 5,147,355 entitled "Cryoablation Catheter and Method for Performing Cryoablation" issued to Friedman. Additionally CryoCath believes CryoCor and co-plaintiff AMS Research Corporation assert AMS's patents in their January 2008 action against CryoCath in a manner that illegally extends at least one patent beyond its scope. Therefore, CryoCath filed counterclaims alleging patent misuse, antitrust, and unfair competition. CryoCath believes CryoCor's case is without merit, and that it does not infringe the two patents asserted in the January 2008 action or the foreign count
'/>"/>